Calcium Carbonate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects. The bioavailability of Deflazacort can be decreased when combined with Calcium Carbonate. The bioavailability of Pregnenolone can be decreased when combined with Calcium Carbonate. The bioavailability of Corticosterone can be decreased when combined with Calcium Carbonate. The serum concentration of Memantine can be increased when it is combined with Calcium Carbonate. The serum concentration of Deferiprone can be decreased when it is combined with Calcium Carbonate. The bioavailability of Fluocinolone Acetonide can be decreased when combined with Calcium Carbonate. The bioavailability of Desoximetasone can be decreased when combined with Calcium Carbonate. The bioavailability of Flumethasone can be decreased when combined with Calcium Carbonate. The bioavailability of Clobetasol can be decreased when combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy. The serum concentration of Pamidronate can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. The serum concentration of Cefpodoxime can be decreased when it is combined with Calcium Carbonate. The bioavailability of Hydrocortisone can be decreased when combined with Calcium Carbonate. The bioavailability of Dexamethasone can be decreased when combined with Calcium Carbonate. The bioavailability of Difluprednate can be decreased when combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy. The serum concentration of Rilpivirine can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate may decrease the excretion rate of Ritobegron which could result in a higher serum level. The bioavailability of Alclometasone can be decreased when combined with Calcium Carbonate. The serum concentration of Cefuroxime can be decreased when it is combined with Calcium Carbonate. The bioavailability of Fluprednidene can be decreased when combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Perazine resulting in a reduced serum concentration and potentially a decrease in efficacy. The bioavailability of Fluocortolone can be decreased when combined with Calcium Carbonate. The bioavailability of Flunisolide can be decreased when combined with Calcium Carbonate. Calcium Carbonate may decrease the excretion rate of Mephentermine which could result in a higher serum level. Calcium Carbonate can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Promazine resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate may decrease the excretion rate of Amphetamine which could result in a higher serum level. Calcium Carbonate may decrease the excretion rate of Methamphetamine which could result in a higher serum level. The bioavailability of Aldosterone can be decreased when combined with Calcium Carbonate. The bioavailability of NCX 1022 can be decreased when combined with Calcium Carbonate. The bioavailability of 5-androstenedione can be decreased when combined with Calcium Carbonate. The bioavailability of Cortisone acetate can be decreased when combined with Calcium Carbonate. The serum concentration of Riociguat can be decreased when it is combined with Calcium Carbonate. The serum concentration of Tiludronic acid can be decreased when it is combined with Calcium Carbonate. The serum concentration of Alendronic acid can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. The bioavailability of Prasterone can be decreased when combined with Calcium Carbonate. The therapeutic efficacy of Mesalazine can be decreased when used in combination with Calcium Carbonate. The serum concentration of Mecamylamine can be increased when it is combined with Calcium Carbonate. Calcium Carbonate may decrease the excretion rate of Chlorphentermine which could result in a higher serum level. Calcium Carbonate can cause a decrease in the absorption of Methotrimeprazine resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy. The bioavailability of anecortave acetate can be decreased when combined with Calcium Carbonate. The bioavailability of Estrone sulfate can be decreased when combined with Calcium Carbonate. Calcium Carbonate may decrease the excretion rate of Benzphetamine which could result in a higher serum level. Calcium Carbonate may decrease the excretion rate of 4-Bromo-2,5-dimethoxyamphetamine which could result in a higher serum level. The serum concentration of Fluvastatin can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate may decrease the excretion rate of 3,4-Methylenedioxyamphetamine which could result in a higher serum level. The serum concentration of Ubidecarenone can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. The therapeutic efficacy of Bismuth Subcitrate can be decreased when used in combination with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Ferric Carboxymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy. The bioavailability of Methylprednisolone can be decreased when combined with Calcium Carbonate. The serum concentration of Hyoscyamine can be decreased when it is combined with Calcium Carbonate. The bioavailability of Flurandrenolide can be decreased when combined with Calcium Carbonate. The bioavailability of Fluticasone furoate can be decreased when combined with Calcium Carbonate. The serum concentration of Sulpiride can be decreased when it is combined with Calcium Carbonate. The bioavailability of Cortexolone 17α-propionate can be decreased when combined with Calcium Carbonate. The bioavailability of Desoxycorticosterone Pivalate can be decreased when combined with Calcium Carbonate. The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Calcium Carbonate. The bioavailability of Fluorometholone can be decreased when combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy. The bioavailability of Beclomethasone dipropionate can be decreased when combined with Calcium Carbonate. Calcium Carbonate can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects. The serum concentration of Gabapentin can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate may decrease the excretion rate of 2,5-Dimethoxy-4-ethylamphetamine which could result in a higher serum level. Calcium Carbonate may decrease the excretion rate of Lisdexamfetamine which could result in a higher serum level. Calcium Carbonate may decrease the excretion rate of Dextroamphetamine which could result in a higher serum level. The bioavailability of Rimexolone can be decreased when combined with Calcium Carbonate. The bioavailability of Estrone can be decreased when combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Isoniazid resulting in a reduced serum concentration and potentially a decrease in efficacy. The bioavailability of Fluocinonide can be decreased when combined with Calcium Carbonate. Calcium Carbonate may decrease the excretion rate of MMDA which could result in a higher serum level. The serum concentration of Technetium Tc-99m medronate can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Perphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy. The bioavailability of Oleoyl-estrone can be decreased when combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Thiethylperazine resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Ferric Citrate resulting in a reduced serum concentration and potentially a decrease in efficacy. The bioavailability of Equilenin can be decreased when combined with Calcium Carbonate. The serum concentration of Dabrafenib can be decreased when it is combined with Calcium Carbonate. The serum concentration of Erlotinib can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Chlortetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate may decrease the excretion rate of Phentermine which could result in a higher serum level. The serum concentration of Chloroquine can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Moricizine resulting in a reduced serum concentration and potentially a decrease in efficacy. The therapeutic efficacy of Cysteamine can be decreased when used in combination with Calcium Carbonate. The serum concentration of Lovastatin can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy. The serum concentration of Atorvastatin can be decreased when it is combined with Calcium Carbonate. The serum concentration of Nilotinib can be decreased when it is combined with Calcium Carbonate. The bioavailability of Budesonide can be decreased when combined with Calcium Carbonate. The bioavailability of HE3286 can be decreased when combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Aceprometazine resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Thioridazine resulting in a reduced serum concentration and potentially a decrease in efficacy. The bioavailability of Tixocortol can be decreased when combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Prochlorperazine resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Carbonate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. The bioavailability of Desonide can be decreased when combined with Calcium Carbonate. The risk or severity of adverse effects can be increased when Calcium Carbonate is combined with Misoprostol. The bioavailability of Equilin can be decreased when combined with Calcium Carbonate. The risk or severity of adverse effects can be increased when Calcium Carbonate is combined with Tolevamer. The serum concentration of Pazopanib can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Thioproperazine resulting in a reduced serum concentration and potentially a decrease in efficacy. The serum concentration of Elvitegravir can be decreased when it is combined with Calcium Carbonate. The serum concentration of Pravastatin can be decreased when it is combined with Calcium Carbonate. The bioavailability of Clobetasone can be decreased when combined with Calcium Carbonate. The serum concentration of Clodronic Acid can be decreased when it is combined with Calcium Carbonate. The bioavailability of Paramethasone can be decreased when combined with Calcium Carbonate. The serum concentration of Quinine can be increased when it is combined with Calcium Carbonate. The serum concentration of Simvastatin can be decreased when it is combined with Calcium Carbonate. The serum concentration of Fexofenadine can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. The serum concentration of Rosuvastatin can be decreased when it is combined with Calcium Carbonate. Calcium Carbonate can cause a decrease in the absorption of Chlorpromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.